US 12,792,011

Application 18/308,802 · Granted Nov 10, 2026

Method for providing a controlling frontend for an operating device

Estimated expiration

October 4, 2043

16y 321d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2021079949: Resource not found (404)
Earliest effective filing
Oct 28, 2021
+ 20 years
Oct 28, 2041
PTA +706d
Oct 4, 2043
No TD
—
Final
Oct 4, 2043

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
April 28, 2023
Earliest effective filing
October 28, 2021
Issue date
November 10, 2026
PTA
+706 days
Base expiry (before PTA)
October 28, 2041

October 28, 2021 + 20 years = October 28, 2041 + 706 PTA days = October 4, 2043

  • Continuation of application PCTEP2021079949, filed Oct 28, 2021

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/308,802 · US 12,792,011

PatentReply compiles the prosecution history behind US 12,792,011: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12792011

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.